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Propolis, a natural resinous product produced by honeybees, is a mixture of plant exudates, waxes and bee salivary enzymes (ß-
glucosidase). A large number of chemical components have been identified in propolis, such as flavonoids, phenolic compounds, 
aromatic acids and diterpenic acids, which are responsible for its various bioactivities. Several propolis biological properties, such 
as its anti-inflammatory activity, are of biomedical interest. Osteoarthritis (OA), a progressive degenerative disease of weight 
bearing joints, affects about one fifth of the population, mostly the elderly. However, its prevalence is expected to increase steeply 
mainly due to the increase of obesity in all age groups. OA is characterized by recurrent inflammatory states, loss of quality of life, 
changes in gait as well as depressive and anxious states. In this study we used an ethanolic extract (EE) of Portuguese propolis 
to study its potential anti-inflammatory effect in an animal model of OA. Experimental OA, induced through the intra-articular 
injection of kaolin/carrageenan, was allowed to develop for a week, corresponding to the acute inflammatory phase of the disease. 
Animal were then administered either the propolis extract or a vehicle for one week. The behavioural impact of the propolis 
treatment was assessed using the pressure application measurement (PAM), to determine changes in mechanical hyperalgesia, 
and the catwalk test, to analyse changes in gait. Administration of propolis EE decreased limb withdrawal latency in OA animals 
indicating an improvement of mechanical hyperalgesia when compared with controls. An increase in the distance between the 
first and the fifth hind toes of propolis-treated animals suggests an improvement in gait when compared with non-treated animals. 
Further studies will analyse the anti-inflammatory effect of propolis extract at the osteoarthritic knee level, namely its impact on 
oedema and inflammatory cell population. 
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Breast cancer is the most common cancer in women worldwide. Metastatic breast cancer cells are known to display V-H+-ATPase 
at the plasma membrane, where it is involved in the acquisition of a more metastatic phenotype. Therefore, V-H+-ATPase 
emerged as a promising candidate for breast cancer therapy, and inhibitors of this pump as potential anticancer drugs. Lactoferrin 
(Lf) is a natural pro-apoptotic glycoprotein with anticancer activity against various human cancer models. Although Lf can regulate 
different apoptotic components, the cellular targets of this protein are still unknown.  We found that bovine Lf (bLf) is preferentially 
cytotoxic for highly metastatic breast cancer cells, in comparison with poorly metastatic and non-tumorigenic breast cells. We 
further demonstrated that this cell-type specific effect against highly metastatic cells is associated with a higher extracellular 
acidification rate (ECAR) and prominent V-H+-ATPase localization at the plasma membrane. Accordingly, we found that bLf 
selectively reduces the ECAR and induces intracellular acidification of the highly metastatic cancer cells, and targets V-H+-
ATPase inhibiting its proton pumping/hydrolytic activities.  In summary, we unveil V-H+-ATPase as a Lf target, which explains its 
selectivity for highly metastatic breast cancer cells. Thus, our findings may lay the foundation for future in vivo studies aiming to 
exploit the use of this natural protein as a novel V-H+-ATPase inhibitor for the treatment of highly metastatic breast cancers, 
seemingly with advantages over the toxic V-H+-ATPase inhibitors currently available since it is safe and well-tolerable. 
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